Related by context. All words. (Click for frequent words.) 83 cell lymphoma CTCL 82 cutaneous T cell 79 refractory cutaneous T 77 Cutaneous T 77 PNP inhibitor 76 lymphoma CTCL 76 dasatinib Sprycel ® 76 systemic anaplastic large 74 hypereosinophilic syndrome 74 leukemia AML 74 refractory chronic lymphocytic 74 CYT# potent vascular disrupting 73 erlotinib Tarceva ® 73 chronic eosinophilic leukemia 73 myelodysplastic myeloproliferative diseases 73 essential thrombocythemia ET 72 PEGylated anti 72 Romidepsin 72 Wafer polifeprosan 72 docetaxel Taxotere ® 72 targeted radiotherapeutic 72 novel histone deacetylase 72 forodesine 72 cetuximab Erbitux R 72 Kit CD# positive 72 relapsed refractory multiple myeloma 72 diarrhea predominant irritable 72 dasatinib Sprycel 72 pan histone deacetylase 72 AAG geldanamycin analog 72 orally administered inhibitor 71 metastatic malignant 71 TNF Tumor Necrosis Factor 71 Zorbtive TM 71 accumulate preferentially 71 R Saizen R 71 FOLOTYN ® 71 lintuzumab SGN 71 docetaxel Taxotere R 71 receptor tyrosine kinase inhibitor 71 Complicated Skin 71 recurrent glioblastoma multiforme 71 methylnaltrexone bromide 71 advanced metastatic renal 71 romidepsin 71 generation purine nucleoside 71 2 methoxyestradiol 71 oropharyngeal candidiasis OPC 71 targeted antifolate 71 Peginterferon alfa 2b 71 oral prodrug 71 pan HDAC inhibitor 71 gastrointestinal stromal tumors GIST 71 Omacetaxine 71 sorafenib tablets 71 IL# PE#QQR 70 oral nucleoside analogue 70 VEGFR2 inhibitor 70 pediatric Crohn disease 70 LEUKINE 70 ADP receptor antagonist 70 nucleoside analog 70 inhalation powder 70 alvespimycin 70 formerly LymphoStat B 70 Gleevec resistant 70 kidney urologic 70 IMiDs R 70 Phase #b/#a clinical 70 antibody MAb 70 metastatic colorectal 70 MKC# MT 70 Personalized Immunotherapy 70 arthritis PsA 70 Sudhir Agrawal D.Phil 70 tumors GIST 70 histone deacetylase HDAC inhibitor 70 subcutaneous formulation 70 PEGylated Fab fragment 70 hormone LHRH antagonist 70 Initiate Phase 70 sodium thiosulfate STS 70 imatinib Gleevec ® 70 Ribavirin causes 70 Tarceva TM 70 VISICOL R 70 Acute Myeloid Leukemia AML 70 papillary renal cell carcinoma 70 lymphoid malignancies 70 oncolytic virus therapies 70 Initiates Enrollment 70 toenail onychomycosis 70 TELINTRA 70 Gel repository corticotropin injection 70 sodium glucose cotransporter 69 Myelodysplastic Syndrome MDS 69 sapropterin dihydrochloride 69 familial amyloidotic polyneuropathy FAP 69 TO AVOID PREGNANCY WHILE 69 Ovitrelle R Serostim 69 Inhalation Aerosol 69 multiple myeloma MM 69 Panzem R 69 Sezary syndrome 69 selective modulator 69 Hsp# Inhibitor 69 luteinizing hormone releasing 69 non splenectomized 69 IAP inhibitor 69 Prodarsan R 69 dependent kinase inhibitor 69 R roscovitine CDK cyclin 69 FUSILEV enhances 69 histone deacetylase inhibitor 69 pharmacologically active isomer 69 vapreotide acetate 69 imatinib resistant 69 MAGE A3 ASCI 69 Orally administered 69 phase III isavuconazole 69 chimeric monoclonal antibody 69 sorafenib Nexavar 69 topical gel formulation 69 R lenalidomide 69 dihydrochloride 69 huN# DM1 69 Vicinium TM 69 ALN HPN 69 alfa 2a 69 lenalidomide Revlimid R 69 IgG1 monoclonal antibody 69 refractory peripheral T 69 PRN FDA Approves 69 nilotinib Tasigna ® 69 visilizumab 69 Fludara ® 69 IMiDs ® 69 Pivotal Phase III 69 Lymphocytic 69 Myocet 69 Methylnaltrexone 69 OMP #R# 69 relapsed mantle 69 ZOLINZA 69 myelofibrosis polycythemia vera 69 XL# XL# 69 hyperphenylalaninemia HPA due 69 vinca alkaloid 69 SPRYCEL ® 69 PDX pralatrexate 69 novel VDA molecule 69 ® lenalidomide 69 relapsed multiple myeloma 69 Initiates Phase II 69 rALLy clinical trial 69 prescribed proton pump 69 Amrubicin 69 atypical Hemolytic Uremic Syndrome 69 YONDELIS 69 castrate resistant prostate cancer 69 INSPIRE Trial Phase III 69 mGluR5 negative 69 relapsed leukemia 69 BENLYSTA ® 69 Xyfid TM 69 alefacept 68 herpetic keratitis 68 refractory gout 68 R bendamustine hydrochloride 68 thalidomide Thalomid 68 Vitrasert R 68 Evoltra ® 68 rheumatoid arthritis psoriatic arthritis 68 Liprotamase 68 leukemia CLL 68 Pegloticase 68 autologous cellular immunotherapy 68 Friedreich Ataxia FRDA 68 Relapsed Refractory 68 liposomal formulation 68 modified glutathione analog 68 developing Bicifadine serotonin 68 refractory acute myeloid 68 AEG# 68 arsenic trioxide injection 68 mTOR mammalian target 68 BCG refractory carcinoma 68 refractory indolent non 68 AVASTIN 68 delta gamma agonist 68 chemosensitizer 68 Phase 2b Clinical Trial 68 OMNARIS HFA 68 severe oral mucositis 68 Lubiprostone 68 iobenguane 68 non nucleoside inhibitor 68 acetonide FA 68 opioid induced constipation OIC 68 monoclonal antibody conjugated 68 Lenocta TM 68 Xanafide 68 SinuNase TM 68 bevacizumab Avastin R 68 Clolar ® 68 vinorelbine tartrate 68 Recombinant Human 68 refractory acute promyelocytic 68 Romiplostim 68 PI3K/Akt pathway inhibitor 68 refractory systemic anaplastic 68 Alfacell proprietary ribonuclease 68 ISTODAX 68 peripherally acting 68 including eniluracil ADH 68 Phase #/#a trial 68 ara C 68 interferon beta 1a infertility 68 Tiuxetan 68 unresectable recurrent 68 anticancer compound 68 LymphoStat B belimumab 68 Leukine ® 68 proteasome inhibitor 68 fumarate 68 paclitaxel Taxol ® 68 CEQ# 68 5 fluorouracil leucovorin 68 IMiDs ® compound 68 acyclovir Lauriad R 68 Receives Orphan Drug Designation 68 Sapacitabine 68 non metastatic osteosarcoma 68 Familial Adenomatous Polyposis FAP 68 pralatrexate injection folate analogue 68 HQK 68 Chronic lymphocytic leukemia 68 IMA# 68 Epratuzumab 68 purpura ITP 68 systemic juvenile idiopathic 68 potent CYP#A# inhibitors 68 intravesical infusion therapy 68 demonstrated antitumor activity 68 severe hypercholesterolemia 68 protein tyrosine phosphatase 1B 68 XL# anticancer compounds 68 post herpetic neuralgia PHN 68 cetuximab Erbitux ® 68 Voreloxin 68 recurrent NSCLC 68 Annamycin 68 topically administered 68 alkylating agent 68 dextromethorphan quinidine 68 virus HCV protease inhibitor 68 Clevudine 68 CYP#A# CYP#D# 68 refractory NSCLC 68 depsipeptide 68 Soliris eculizumab 68 oral beclomethasone dipropionate 67 Neulasta R 67 catheter occlusion 67 posterior uveitis 67 markets HP Acthar 67 GVAX ® 67 lexidronam injection 67 Gamunex C 67 novel emulsion formulation 67 Granulocyte Colony Stimulating Factor 67 Maribavir 67 INVANZ 67 MYLOTARG 67 R rilonacept Injection 67 sunitinib Sutent ® 67 Inhalation Solution 67 gemcitabine Gemzar ® 67 immunomodulatory therapy 67 Traficet EN 67 Cloretazine 67 metastatic GIST 67 idiopathic thrombocytopenic purpura ITP 67 mertansine 67 mesylate 67 Hodgkin lymphoma HL 67 pediatric acute lymphoblastic 67 vaginal candidiasis 67 Systemic lupus erythematosus SLE 67 Amgen Neulasta R 67 treat chronic sinusitis 67 gastrointestinal stromal tumors 67 severe hypersensitivity reactions 67 octreotide implant 67 oral proteasome inhibitor 67 metastatic neuroendocrine tumors 67 CTAP# Capsules 67 xanthine oxidase inhibitor 67 Myelofibrosis 67 Initiate Clinical Trial 67 relapsed MM 67 rheumatoid arthritis RA psoriatic 67 MKC# MKC# PP 67 N acetylgalactosamine 6 67 Camptosar ® 67 brand ciclesonide HFA 67 Chronic Lymphocytic Leukemia CLL 67 Pharmacokinetics PK 67 C1 esterase inhibitor 67 carcinoid syndrome 67 unique alkylating agent 67 hyaluronidase enzyme 67 Plicera 67 R metformin Concor 67 R bisoprolol Euthyrox 67 intranasal formulation 67 Brentuximab Vedotin SGN 67 class anticancer quinolone 67 cortisol synthesis 67 5 FU leucovorin 67 ® bortezomib 67 Prolongs Survival 67 phase IIb clinical 67 ALN TTR 67 Irinotecan 67 GW# [003] 67 Diffuse Large B 67 Pegasys ® 67 Enzyme Replacement Therapy 67 PROCTOCORT R 67 trastuzumab Herceptin R 67 Xeloda ® 67 Meets Primary Endpoint 67 human C1 inhibitor 67 interferon gamma 1b 67 Oracea TM 67 PKC# 67 Elagolix 67 TNF alpha selectively neutralizing 67 multi kinase inhibitor 67 LHRH receptor positive 67 adalimumab Humira 67 Imatinib mesylate 67 Aflibercept 67 Clofarabine 67 Pivotal Phase 67 CDK cyclin dependent 67 MOVIPREP R 67 soluble tumor necrosis 67 hepatitis C HCV 67 non peptidic protease 67 hypoxia activated prodrug 67 imatinib Gleevec 67 Albuferon TM 67 IAP inhibitors 67 PEGINTRON TM 67 AA amyloidosis 67 Cimzia TM 67 Angiotensin Converting Enzyme 67 overactive bladder VANTAS 67 Onalta ™ 67 MGd 67 miconazole Lauriad ® 67 Solazed TM 67 ALN PCS 67 Vidaza R 67 FDA APPROVES 67 prokinetic agent 67 fosbretabulin 67 refractory chronic myeloid 67 NEBIDO R 67 alpha folate receptor 67 chronic immune thrombocytopenic 67 evaluating picoplatin 67 sunitinib malate 67 oropharyngeal candidiasis 67 Enzastaurin 67 DNA methyltransferase inhibitors 67 erlotinib Tarceva R 67 atypical hemolytic uremic syndrome 67 radiation sensitizer 67 Xcellerated T Cells 67 superficial basal cell carcinoma 67 induced macular edema 67 R sorafenib tablets 67 Tezampanel 67 subependymal giant cell 67 vitreoretinal disorders 67 Advanced Renal Cell 67 unresectable locally advanced 67 #I TM# 67 vWD 67 Cell Lymphoma CTCL 67 topically applied SEPA 67 eosinophilic asthma 67 oral ridaforolimus 67 BENLYSTA TM 67 metastatic gastric 67 Kamada AAT 67 Nexavar sorafenib 67 reslizumab 67 selective antagonist 67 myelodysplastic syndrome MDS 67 BARACLUDE ® 67 Opterone R 67 Refractory Hodgkin Lymphoma 67 immune idiopathic thrombocytopenic 67 mTOR inhibitor 67 Intravenous Human 67 HBeAg negative 67 oral picoplatin 67 HP Acthar Gel repository 67 Lupus Nephritis 67 MKC# 67 hepatitis B HBV 67 PANVAC VF 67 ACTEMRA TM 67 MEK inhibitor 67 lucinactant 66 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 66 Glioblastoma Multiforme 66 TRANSDUR ® 66 corticotropin injection 66 refractory Hodgkin lymphoma 66 Phase 2b Trial 66 ceftazidime 66 Vidaza azacitidine 66 metastatic castration resistant 66 Velcade bortezomib 66 TLK# 66 psoriasis rheumatoid arthritis 66 5 HT3 antagonist 66 indolent follicular non 66 brivanib 66 molecular imaging radiopharmaceutical 66 IBS C 66 thetreatment 66 GTC recombinant human 66 Chronic Idiopathic Constipation 66 Dementia Related Psychosis 66 DIFICID ™ 66 metaglidasen 66 histamine dihydrochloride 66 Alemtuzumab 66 highly purified pasteurized 66 GTC recombinant form 66 sarcoma melanoma 66 cell carcinoma RCC 66 MT# MEDI 66 CD4 monoclonal antibody 66 proliferator activated receptor 66 icatibant 66 Belimumab 66 inflammatory PDE 66 gefitinib Iressa 66 Phase IIb clinical trials 66 situ CIS 66 rHuPH# recombinant human 66 investigational oral inhibitor 66 beta 1a 66 superficial bladder cancer 66 Bazedoxifene 66 ONCASPAR 66 aflibercept VEGF Trap 66 complement inhibitor eculizumab 66 Zenvia ™ 66 IMiDs 66 Factor VIIa 66 indinavir Crixivan 66 Luveris R Ovidrel R 66 Onco TCS 66 cisplatin gemcitabine 66 nilotinib Tasigna 66 Insegia 66 Curaxin CBLC# 66 PDE4 inhibitor 66 drug pipeline TAFA# 66 Talabostat 66 Crofelemer budesonide foam 66 Vascular Disrupting Agent 66 MyVax R 66 HuMax CD4 66 selective kinase inhibitor 66 Gonal f R 66 sapacitabine CYC# 66 Ixempra 66 selective immunoproteasome inhibitor 66 Darinaparsin 66 vWF 66 small molecule Hedgehog 66 gastrointestinal stromal tumors GISTs 66 Cloretazine ® 66 Pathway Inhibitor 66 HER2 positive metastatic breast 66 ganciclovir 66 generation Hsp# inhibitor 66 5 lipoxygenase inhibitor 66 TRISENOX ® 66 immunotherapeutic agent 66 constipation OIC 66 AMEVIVE 66 ALVESCO ® 66 telomerase therapeutic 66 cystic fibrosis bronchiectasis 66 diarrhea fatigue asthenia 66 Granted Orphan Drug 66 lung pancreatic 66 HGS# 66 hormone refractory metastatic prostate 66 nucleotide analog 66 Fludarabine 66 non alcoholic steatohepatitis 66 chronic myeloid 66 plus DOXIL 66 CD# CEA 66 temsirolimus Torisel 66 TRIOLEX HE# APOPTONE HE# 66 ThermoDox R 66 leukemia APL 66 Copegus ribavirin 66 unresectable stage 66 containing granisetron 66 Kuvan R 66 Philadelphia Chromosome Positive 66 leukemia ALL 66 Nitazoxanide 66 humanized interleukin 6 66 Acute myeloid leukemia 66 MCSP respectively 66 fallopian tube cancers 66 HGS ETR1 mapatumumab 66 phase IIb trial 66 Letairis ambrisentan 66 Janus kinase 66 Syndrome LEMS 66 forodesine hydrochloride 66 TELINTRA R 66 Phase IIb Trial 66 Cimzia ® certolizumab pegol 66 Oral Fingolimod 66 monoclonal antibody IgG1 Mab 66 esophageal candidiasis 66 allosteric modulator NAM 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 alpha interferons 66 metformin XR 66 Refractory Peripheral T 66 PROSTASCINT R 66 Cell Lymphoma 66 metastatic castrate resistant 66 FOLFOX6 chemotherapy regimen 66 Carcinoid tumors 66 trastuzumab DM1 T DM1 66 Aviptadil 66 acute myelogenous leukemia AML 66 carmustine implant 66 Metastatic Melanoma 66 Forodesine HCl 66 Ozarelix 66 TYZEKA 66 polycythemia vera essential thrombocythemia 66 diabetic gastroparesis 66 HDAC Inhibitor 66 Pralatrexate 66 bladder ovarian 66 evaluating tivozanib 66 AVONEX ® 66 treatment naive genotype 66 investigational monoclonal antibody 66 VALSTAR 66 octreotide acetate 66 CHOP chemotherapy 66 Triapine 66 pegfilgrastim 66 investigational immunotherapy 66 interferon alfa 2b 66 personalized cellular immunotherapy 66 hypertrichosis occurred 66 ribavirin RBV 66 metastatic renal cell carcinoma 66 brivaracetam 66 thymalfasin 66 novel topoisomerase 66 Anti VEGF 66 Seliciclib 66 agonistic human 66 Zavesca R 66 Soliris TM eculizumab 66 oral dual endothelin 66 PEG SN# 66 seliciclib CYC# 66 Gemzar ® 66 acute GvHD 66 resistant hormone refractory 66 Zevalin R Ibritumomab 66 rALLy 66 HCD# [002] 66 tyrosine kinase inhibitor TKI 66 LymphoStat B TM 66 Eculizumab 66 Campath ® 66 systemic fungal infections 66 relapsing remitting MS RRMS 66 Blinatumomab 66 metformin HCl 66 Degarelix 66 FUSILEV ® 66 autoantibody positive 66 humanized therapeutic 66 Silodosin 66 zanolimumab 66 Anaplastic large 66 vaccines oncolytic virus 66 ELADUR ™ 66 GATTEX ® 66 SinuNase ™ 66 metastatic colorectal carcinoma 66 mitoxantrone plus 66 Actemra tocilizumab 66 Pemetrexed 66 dihydrochloride Tablets 66 transthyretin TTR mediated amyloidosis 66 Mg Usa 66 Veronate R 66 Gleevec imatinib mesylate 66 ergot derivatives 66 Completes Patient Enrollment 66 Peginterferon 66 Certolizumab pegol 66 non resectable 66 MabThera Rituxan 65 dyskinesia PD LID 65 liver resection surgeries 65 metastatic hormone refractory 65 D aspartate NMDA receptor 65 ZEVALIN ® 65 Panzem R NCD 65 pouchitis 65 PGL# 65 OHR/AVR# 65 steroid refractory ulcerative 65 delivers fluocinolone acetonide FA 65 T#I mutant 65 primary hypercholesterolemia 65 hyperplasia BPH 65 huC# DM4 65 Chronic lymphocytic leukemia CLL 65 Vandetanib 65 chronic idiopathic thrombocytopenic purpura 65 oral dihydropyrimidine dehydrogenase DPD 65 substantially excreted 65 selective phosphodiesterase 65 investigational humanized monoclonal antibody 65 Bendamustine 65 antiangiogenesis therapies 65 Phase 2a Clinical Trial 65 oral ghrelin agonist 65 Bezielle 65 Patients Treated With 65 Navelbine ® 65 CD# expressing 65 Severe Sepsis 65 acute myeloid 65 plus prednisone prednisolone 65 polycythemia vera PV 65 Archexin 65 Cannabinor 65 recurrent glioblastoma 65 BRIM2 65 targeting CD# 65 tinidazole 65 apoptosis inducer 65 Vidaza ® 65 histone deacetylase HDAC inhibitors 65 Amgen Neulasta ® 65 Quinamed R 65 BiovaxID TM 65 non thiazolidinedione TZD 65 factor G CSF 65 Dacogen injection 65 paclitaxel Taxol R 65 complicated intra abdominal 65 Factor Receptor 65 Saizen R 65 AKT inhibitor 65 HCV polymerase inhibitors 65 HoFH 65 Quinamed 65 immune globulin intravenous 65 prostanoid 65 Lenalidomide 65 Application MAA 65 hereditary deficiency 65 ALVESCO R 65 oxypurinol 65 Mg Uk 65 Daclizumab 65 peritumoral brain edema 65 Zenvia TM 65 peptidic compound 65 Ceflatonin R 65 pregabalin Lyrica 65 AQ4N 65 echinocandin 65 Epothilone D 65 NS5b 65 Kuvan sapropterin dihydrochloride 65 Soft Tissue Sarcoma 65 biologic DMARD 65 Tasimelteon 65 KSP inhibitor 65 sargramostim 65 mitogen activated ERK kinase 65 inhibit replication 65 Rituxan rituximab 65 Orphan Drug status 65 COPEGUS R 65 Adjuvant Treatment 65 cardiometabolic diseases Glucophage 65 directed radiotherapeutic antibody 65 Fast Track Status 65 Hodgkin lymphoma NHL 65 SUPPRELIN R LA 65 diabetic neuropathic pain 65 relapsed Acute Myeloid 65 Acute myeloid leukemia AML 65 MELAS 65 Nexavar ® 65 NASH Huntington 65 BCG refractory 65 panitumumab Vectibix 65 Treanda bendamustine 65 dexamethasone Decadron 65 refractory CTCL 65 Li Fraumeni Syndrome 65 aripiprazole Abilify 65 ISTODAX ® 65 samarium Sm 65 triciribine phosphate monohydrate 65 Ph + acute lymphoblastic 65 evaluating satraplatin 65 gastrointestinal stromal tumor 65 demethylating agent 65 Prodarsan 65 HCV RNA polymerase 65 recombinant biopharmaceutical 65 Completes Enrollment 65 Palifosfamide 65 rasagiline tablets 65 systemic RNAi therapeutic 65 anti amnesic 65 Dapagliflozin 65 Uricase PEG 65 candidates Azedra TM 65 severe malignant osteopetrosis 65 acid phosphatase PAP 65 Luteinizing Hormone Releasing Hormone 65 cell acute lymphoblastic 65 DURIN TM 65 multicenter Phase III 65 chemotherapy induced neutropenia 65 DU #b 65 small molecule thrombopoietin 65 Begins Dosing 65 Vidofludimus 65 highly selective inhibitor 65 intravesical instillation 65 mu opioid receptor antagonist 65 Zolinza 65 OncoVex 65 ketolide antibiotic 65 Tanespimycin 65 QUADRAMET R 65 previously untreated follicular 65 sapropterin dihydrochloride Tablets 65 influenza BCX# purine nucleoside 65 disease GERD 65 Alferon LDO 65 nanofiltered plasma derived 65 Immunotherapeutic 65 Elotuzumab 65 HCl PEPCID ® famotidine 65 FEMALES SHOULD BE ADVISED 65 volociximab 65 stage IIIb IV 65 epigenetic therapies 65 Azedra 65 Vitrasert ® 65 Vaprisol 65 Pruvel TM 65 prescription laxative 65 itraconazole Sporanox 65 stage IIIB 65 AMMONUL R sodium phenylacetate 65 pegylated interferon alpha 65 insulin glulisine 65 miconazole Lauriad R 65 metastatic renal 65 Cerebril TM 65 Gliadel R 65 lexidronam injection PROSTASCINT 65 oral isoform selective HDAC 65 opioid induced constipation 65 YONDELIS R 65 opioid induced bowel dysfunction 65 BAY #-# 65 PD LID 65 Hydrochlorothiazide Tablets 65 receiving chemoradiation therapy 65 Initiates Phase III 65 PROVENGE ® 65 First Patient Dosed 65 sunitinib Sutent 65 polysaccharide polymer 65 Specifid 65 Combination REOLYSIN R 65 PEGylated interferon beta 1a 65 imatinib mesylate 65 bortezomib Velcade 65 developing Zerenex ferric 65 Ranolazine 65 reversible inhibitor 65 Troxatyl 65 stable angina pectoris 65 targeting Inflammatory Bowel 65 ospemifene 65 cromolyn sodium 65 forodesine purine nucleoside phosphorylase 65 receiving INTRON 65 ACTIQ ® 65 BLP# Liposome Vaccine 65 Cetrorelix 65 Protease Inhibitor 65 pancreatic enzyme replacement 65 TTR amyloidosis 65 refractory multiple myeloma 65 CD3 monoclonal antibody 65 microtubule inhibitor 65 recurrent metastatic ovarian cancer 65 Alinia 65 DORIBAX 65 myeloproliferative diseases 65 CINTREDEKIN BESUDOTOX 65 Aplidin R 65 metabolic inhibitor 65 CCR9 antagonist 65 marketed pegylated interferons 65 p# MAP kinase inhibitor 65 Investigational Oral 65 Bosutinib 65 ZADAXIN ® 65 secondary hyperparathyroidism 65 Zemiva ™ 65 treatment naïve genotype 65 Mylan Receives Approval 65 immunomodulator 65 Systemic Sclerosis 65 RELISTOR ® 65 malignant ascites 65 chronic thromboembolic pulmonary 65 triggers apoptosis programmed 65 r hGH 65 minimally symptomatic metastatic castrate 65 non porcine pancreatic 65 follicular non 65 Parkinson disease levodopa induced 65 plus gemcitabine 65 somatostatin analogue 65 RhuDex R 65 estrogen receptor antagonist 65 Temsirolimus 65 JAK2 Inhibitor 65 radiolabeled TM# 65 Neulasta ® 65 hematologic disorders 65 ibritumomab tiuxetan 65 Squalamine 64 lupus nephritis 64 Amigal TM 64 Myozyme alglucosidase alfa 64 REPRONEX R menotropins 64 EOquin TM 64 pathophysiological effects 64 ZACTIMA 64 Paraplatin ® 64 exocrine pancreatic insufficiency EPI 64 8mg/kg 64 MyVax ® 64 apomorphine hydrochloride 64 cyclobenzaprine hydrochloride extended 64 active ankylosing spondylitis 64 Cytarabine 64 Genasense ® 64 AMMONUL R 64 cyclophosphamide chemotherapy 64 TKB# 64 pseudobulbar affect PBA 64 advanced carcinoid 64 cyclophosphamide methotrexate 64 CML CP 64 BYETTA ® 64 Azacitidine 64 miconazole MBT 64 AGGRASTAT R Injection tirofiban 64 sublingual tablets 64 investigational antiplatelet agent 64 injection USP 64 benign prostatic hypertrophy BPH 64 CCR5 antagonist 64 metastatic bladder 64 Leukemias 64 reversible inhibitors 64 unstable angina UA 64 CLL SLL 64 GATTEX ™ 64 investigational oral hepatitis C 64 Forodesine 64 oral candidiasis 64 Endologix Powerlink System 64 metastatic malignant melanoma 64 aggressive systemic mastocytosis 64 plus COPEGUS 64 Systemic lupus erythematosus 64 angiogenesis inhibitor 64 Fludara 64 Copegus R 64 Follicular Lymphoma 64 transplantation HCT 64 JAK1 64 Edurant 64 RNAi therapeutic targeting 64 approved incretin mimetic 64 Ophena TM 64 HyperAcute 64 Diabetic Macular Edema 64 Naive Patients 64 androgen independent 64 rilonacept 64 bortezomib Velcade R 64 Aryplase 64 EGFR HER2 64 gemcitabine Gemzar R 64 Etravirine 64 NAGS deficiency 64 gastrin analogue TT 64 overactive bladder VANTAS R 64 Lenocta 64 registrational trial 64 MYCAMINE 64 Single Dose 64 Icatibant 64 CIMZIA TM 64 Pivotal Trial 64 Rebif ® 64 Iluvien ® 64 BUPHENYL 64 A1PI 64 chronic lymphocytic leukemia CLL 64 gastro intestinal inflammation 64 mycosis fungoides 64 Serostim R 64 T#I [002] 64 ocular formulation 64 Initiates Clinical Trial 64 trastuzumab Herceptin ® 64 topical antifungal 64 non myeloid malignancies 64 IN PATIENTS WITH 64 cIAI 64 investigational pharmacologically unique 64 Janus Kinase 64 ZYBRESTAT fosbretabulin 64 carmustine 64 FOLFOX chemotherapy 64 INTEGRILIN ® 64 nephropathic cystinosis 64 Interferon beta 1b 64 Myelodysplastic syndromes MDS 64 buccal tablets 64 PRT# 64 DEB# 64 calcineurin inhibitors 64 OvaRex ® MAb 64 included exfoliative dermatitis 64 Chemokine Receptor 64 Liposomal 64 docetaxel Taxotere 64 pheochromocytoma 64 metastatic dermatofibrosarcoma protuberans DFSP 64 glioblastoma multiforme GBM 64 Hedgehog Pathway Inhibitor 64 treat male hypogonadism 64 lipoglycopeptide 64 5 HT3 receptor 64 AVAPRO 64 homozygous familial hypercholesterolemia 64 paclitaxel cisplatin 64 leading oral taxane 64 inhibitor PPI